Founded in 1989, Fosun Diagnostics (Shanghai) Co., Ltd. (Fosun Diagnostics) always upholds the mission of "integrating innovative diagnostic techniques and safeguarding lives and health of the world". Focusing on the IVD industry, it promotes the development and implementation of innovative technologies and products and is committed to becoming a world-leading scientific and technological innovator in the field of comprehensive solutions for medical diagnosis.

On May 18, 2021, "Fosun Long March" was officially renamed "Fosun Diagnostics". It has established six major R&D and production bases in Shanghai, Jiangsu, Hunan, Anhui, Shenzhen and other provinces and cities in China, to continuously improve the integrated industrial layout of "from diagnosis to treatment" for the R&D and manufacturing of in vitro diagnostic instruments and reagents. It has developed a variety of products for clinical chemistry, immunoassays, molecular diagnosis, microbiology and POCT, etc. and has built a large automatic pipeline and a small POCT product group focusing on six major diseases including tumors, digestive and metabolic diseases, cardiovascular and cerebrovascular diseases, reproductive disease, central nervous system diseases and infections.